how does glp-1 decrease appetite The Shocking Truth about GLP-1s

The usefulness of continuous glucose monitoring in the diagnostic approach to hypoglycemia after metabolic surgery Mini-invasive Surg

Patients should be advised that they may not have glycemic improvement for 24 weeks after initiating treatment with long-acting GLP-1 receptor agonists

Emerging concerns: Recent reports have raised concerns about muscle and bone loss, a potential consequence of rapid weight loss, as well as the possibility of gastroparesis

Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)

What GLP-1 Medications Do in Your Body GLP-1 receptor agonists were designed to help control blood sugar and, more recently, to help with weight management

Treatment with liraglutide injection 1.2 mg and liraglutide injection 1.8 mg resulted in statistically significant reductions in HbA1c relative to sitagliptin 100 mg (Table 5)